2026 Product Development Science & Technology Cell Line Development Co-Op (June - Dec) (Masters)

Company Description

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

Job Description

Envision spending your summer working with energetic colleagues and inspirational leaders, all while gaining world-class experience in one of the most dynamic organizations in the pharmaceutical industry. This is a reality for AbbVie AbbVie Co-Ops.

The Science & Technology (S&T) organization within AbbVie Operations leads the optimization, validation, implementation, continuous improvement, and global technical support for therapeutic proteins. The S&T Co-Op program provides students with robust projects based on business need. Students will do meaningful work that has a real impact on our business and patients worldwide. Possible 2026 Fall Co-Op assignments are in the following departments: 

Bio-Process Development: The department’s mission is to design, deliver and support the biologics manufacturing process for AbbVie’s pipeline and partnered products through clinical development and commercial life cycle with quality, speed, and manufacturing excellence. This is achieved through a focus on targeted product quality, CMC acceleration, people development, and efficient workflows. Key groups include: Cell line development, Cell culture process development, Purification process development, Scale-up lab, and Analytical development.

Cell Line Development: Responsibilities include performing manual and automated processes to generate monoclonal cell lines and to execute various studies on these cell lines leading to the collection of a comprehensive data package for the final clone selection. The team utilizes state-of-the-art automation instrumentation and cutting-edge molecular biology tools at various stages of cell line expansions and performance evaluation. The group